至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe

Cell death & disease. 2020-07; 
Gastl B, Klotz-Noack K, Klinger B, Ispasanie S, Salib KHF, Zuber J, Mamlouk S, Bublitz N, Blüthgen N, Horst D, Morkel M, Schäfer R, Sers C
Products/Services Used Details Operation
Oligo pool 55K Agilent custom array by CustomArray Inc. and contained the respective shRNA sequence, an Get A Quote

摘要

关键词